Related Experiment Video
Updated: Jun 27, 2026

Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens
Published on: May 23, 2014
Ectopic and eutopic stromal endometriotic cells have a damaged ceramide signaling pathway to apoptosis
Agnieszka Chrobak1, Urszula Sieradzka, Rafał Sozański
1Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland. chrobak@iitd.pan.wroc.pl
Objective:
To investigate whether sphingosine analogues, which activate the ceramide signaling pathway to apoptosis, can cause the death of ectopic (EEC) and eutopic stromal endometriotic cells (EEU), as well as healthy eutopic stromal endometrial cells (HEU).
Design:
The EEC, EEU, and HEU isolated from fertile and infertile women with endometriosis were cultured for 48 hours in RPMI medium with 10% fetal calf serum (FCS) and with 2.5-10 microM sphingosine analogues.
Setting:
A clinic for the treatment of endometriosis and basic research laboratories.
Patient(S):
Nineteen women with follicular cyst and 16 women with endometriosis.
Main Outcome Measure(S):
The percentage of proliferating cells was determined by 93-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide (MTT) assay. Apoptosis and cell cycle were detected by fluorescence-activated cell sorter (FACS) Calibur flow cytometer.
Result(S):
The viability of EEC after exposure to 10 microM sphingosine analogues was 59.5% +/- 9.7% for D-sphingosine and 77.65 +/- 9.7% for DL-erythro-sphingosine, the viability of EEU was 69.2% +/- 14.2% and 42.0% +/- 15.5%, whereas the viability of comparative HEU was 9.0% +/- 4.8% and 18.8% +/- 8.3%, respectively. The differences were significant using the Mann-Whitney test. The apoptotic level of the cells treated with 10 microM sphingosine analogues for comparative HEU was 42.8% +/- 7.5% for D-sphingosine and 42.5% +/- 10.5% for DL-erythro-sphingosine, whereas for EEC this was 16.7% +/- 5.5% for D-sphingosine and 14.1% +/- 4.4% for DL-erythro-sphingosine and for EEU this was 14.3% +/- 4.7% and 22.9% +/- 8.9%, respectively.
Conclusion(S):
Ectopic and eutopic stromal endometrial cells from women with endometriosis have a damaged ceramide-downstream pathway to apoptosis.
Insights
Sphingosine analogues induce apoptosis in healthy endometrial cells but are less effective in ectopic and eutopic endometriotic cells. This suggests a damaged apoptosis pathway in endometriosis, impacting treatment strategies.
Area of Science:
- Cell biology
- Molecular medicine
- Gynecology
Background:
- Endometriosis is a condition characterized by the presence of endometrial tissue outside the uterus.
- The ceramide signaling pathway plays a crucial role in apoptosis (programmed cell death).
- Sphingosine analogues are compounds that can activate this pathway.
Purpose of the Study:
- To determine if sphingosine analogues can induce apoptosis in ectopic endometrial cells (EEC), eutopic stromal endometriotic cells (EEU), and healthy eutopic stromal endometrial cells (HEU).
- To investigate the potential of sphingosine analogues as a therapeutic agent for endometriosis by examining their effect on different endometrial cell types.
Main Methods:
- Endometrial cells (EEC, EEU, HEU) were isolated from women with and without endometriosis.
- Cells were cultured and treated with varying concentrations of sphingosine analogues for 48 hours.
- Cell viability was assessed using the MTT assay.
- Apoptosis and cell cycle progression were analyzed via fluorescence-activated cell sorting (FACS).
Main Results:
- Sphingosine analogues significantly reduced the viability of healthy eutopic endometrial cells (HEU) compared to ectopic (EEC) and eutopic stromal endometriotic cells (EEU).
- The apoptotic level was significantly higher in HEU cells treated with sphingosine analogues than in EEC and EEU cells.
- EEC and EEU cells showed a less pronounced apoptotic response to sphingosine analogues, indicating potential resistance.
Conclusions:
- Ectopic and eutopic stromal endometriotic cells from women with endometriosis exhibit a defect in the ceramide-dependent apoptosis pathway.
- This impaired apoptotic pathway in endometriosis may contribute to the disease's persistence and resistance to certain therapies.
- Targeting the ceramide pathway or sphingosine analogues may require different strategies for treating endometriosis effectively.
More Related Videos
Related Concept Videos
The Extrinsic Apoptotic Pathway
Apoptosis
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury V: Apoptosis and Autophagy
Caspases
Stem Cell Niche

